NCT/Study#
N/A /
BI-SPECIFIC-T-CELL-OUTCOMES
Outcomes of Multiple Myeloma Patients who are Refractory to Bi-Specific T-Cell Engagers
DISEASE GROUP:
Multiple Myeloma
current phase:
N/A
STUDY STATUS:
Enrolling
Location:
Hackensack, NJ
For More information:
